Development of the Clinical Assessment Scale in Autoimmune Encephalitis

Authors
Byung Chan LimYong Won ChoTae-Ho YangHee Jin KimYoung-Soo KimYong Seo KooByeongsu ParkKeun-Hwa JungManho KimKyung-Il ParkKi-Young JungKon ChuSang Kun LeeDong Wook KimJung-Ah LimSoon-Tae LeeJangsup MoonJin-Sun JunTae-Joon KimYong-Won ShinSuhailah AbdullahJung-Ick ByunJun-Sang SunwooKeun Tae KimTae-Won YangWoo-Jin LeeHye-Jin Moon
Department
Dept. of Neurology (신경과학)
Issue Date
2019
Citation
Annals of Neurology, Vol.85(3) : 352-358, 2019
ISSN
1531-8249
Abstract
Objective: There is no scale for rating the severity of autoimmune encephalitis (AE). In this study, we aimed to develop a novel scale for rating severity in patients with diverse AE syndromes and to verify the reliability and validity of the developed scale. Methods: The key items were generated by a panel of experts and selected according to content validity ratios. The developed scale was initially applied to 50 patients with AE (development cohort) to evaluate its acceptability, reproducibility, internal consistency, and construct validity. Then, the scale was applied to another independent cohort (validation cohort, n = 38). Results: A new scale consisting of 9 items (seizure, memory dysfunction, psychiatric symptoms, consciousness, language problems, dyskinesia/dystonia, gait instability and ataxia, brainstem dysfunction, and weakness) was developed. Each item was assigned a value of up to 3 points. The total score could therefore range from 0 to 27. We named the scale the Clinical Assessment Scale in Autoimmune Encephalitis (CASE). The new scale showed excellent interobserver (intraclass correlation coefficient [ICC] = 0.97) and intraobserver (ICC = 0.96) reliability for total scores, was highly correlated with modified Rankin scale (r = 0.86, p < 0.001), and had acceptable internal consistency (Cronbach α = 0.88). Additionally, in the validation cohort, the scale showed high interobserver reliability (ICC = 0.99) and internal consistency (Cronbach α = 0.92). Interpretation: CASE is a novel clinical scale for AE with a high level of clinimetric properties. It would be suitable for application in clinical practice and might help overcome the limitations of current outcome scales for AE.
URI
http://kumel.medlib.dsmc.or.kr/handle/2015.oak/41914
Appears in Collections:
1. Journal Papers (연구논문) > 1. School of Medicine (의과대학) > Dept. of Neurology (신경과학)
Keimyung Author(s)
김근태; 조용원
Full Text
https://onlinelibrary.wiley.com/doi/full/10.1002/ana.25421
File in this Item
 사서에게 요청하기
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE